Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
endothelial progenitor cells (1 trial)
Ischemia (Phase 2)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Phase 2)
Vascular Diseases (Phase 2)
Trials (1 total)
Trial APIs (1 total)